Gong, Y.; Klein Wolterink, R.G.J.; Gulaia, V.; Cloosen, S.; Ehlers, F.A.I.; Wieten, L.; Graus, Y.F.; Bos, G.M.J.; Germeraad, W.T.V.
Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity. Cancers 2021, 13, 2579.
https://doi.org/10.3390/cancers13112579
AMA Style
Gong Y, Klein Wolterink RGJ, Gulaia V, Cloosen S, Ehlers FAI, Wieten L, Graus YF, Bos GMJ, Germeraad WTV.
Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity. Cancers. 2021; 13(11):2579.
https://doi.org/10.3390/cancers13112579
Chicago/Turabian Style
Gong, Ying, Roel G. J. Klein Wolterink, Valeriia Gulaia, Silvie Cloosen, Femke A. I. Ehlers, Lotte Wieten, Yvo F. Graus, Gerard M. J. Bos, and Wilfred T. V. Germeraad.
2021. "Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity" Cancers 13, no. 11: 2579.
https://doi.org/10.3390/cancers13112579
APA Style
Gong, Y., Klein Wolterink, R. G. J., Gulaia, V., Cloosen, S., Ehlers, F. A. I., Wieten, L., Graus, Y. F., Bos, G. M. J., & Germeraad, W. T. V.
(2021). Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity. Cancers, 13(11), 2579.
https://doi.org/10.3390/cancers13112579